MARVELOUS MICROBIOME
LIVE

Serial Number

88960829

Owner

Arranta Bio Holdings, LLC

Attorney

Jessica L. Rothstein

First Use Date

Nov 13, 2020

Filing Date

Jun 11, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MARVELOUS MICROBIOME Trademark

Serial Number: 88960829 • Registration: 6412717

MARVELOUS MICROBIOME is a trademark filed by Arranta Bio Holdings, LLC on June 11, 2020. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Arranta Bio Holdings, LLC (7 trademarks)

Watertown, MA 02472

Entity Type: 16

Trademark Details

Filing Date

June 11, 2020

Registration Date

July 6, 2021

First Use Anywhere

November 13, 2020

First Use in Commerce

November 13, 2020

Published for Opposition

October 6, 2020

Goods & Services

Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, biotherapeutic products, health care products and medical products; treatment of materials, namely, pharmaceutical, biologic, and chemical products and their components used in the manufacture of pharmaceuticals, biotherapeutic products, and biopharmaceuticals; manufacture of pharmaceuticals, biotherapeutic products, and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, biopharmaceuticals, and biotherapeutic products; contract manufacturing of pharmaceuticals, biopharmaceuticals, and biotherapeutic products and reagents

Research and development of pharmaceutical products, biopharmaceutical products, biotherapeutic products, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, biotherapeutic products, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 6, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 6, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 3, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 2, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 18, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 17, 2021 AITU
USE AMENDMENT FILED
May 6, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
May 6, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 1, 2020 NOAM
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 19, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 19, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 19, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 19, 2020 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 6, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 6, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 16, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 28, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 28, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 28, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 28, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 28, 2020 CNEA
ASSIGNED TO EXAMINER
Aug 24, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 9, 2020 NWOS
NEW APPLICATION ENTERED
Jun 15, 2020 NWAP